Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $205 - $401
-14 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$24.31 - $33.6 $218 - $302
-9 Reduced 39.13%
14 $0
Q1 2021

May 06, 2021

SELL
$33.06 - $56.93 $462 - $797
-14 Reduced 37.84%
23 $1,000
Q4 2020

Feb 03, 2021

BUY
$39.09 - $57.4 $429 - $631
11 Added 42.31%
37 $2,000
Q3 2020

Oct 30, 2020

BUY
$28.43 - $44.67 $739 - $1,161
26 New
26 $1,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.